U.S. flag

An official website of the United States government

NM_017849.4(TMEM127):c.410-2A>C AND Pheochromocytoma, susceptibility to

Germline classification:
risk factor (1 submission)
Last evaluated:
Mar 1, 2010
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000000127.12

Allele description [Variation Report for NM_017849.4(TMEM127):c.410-2A>C]

NM_017849.4(TMEM127):c.410-2A>C

Gene:
TMEM127:transmembrane protein 127 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q11.2
Genomic location:
Preferred name:
NM_017849.4(TMEM127):c.410-2A>C
Other names:
IVS3-2A>C(p.L138fs)
HGVS:
  • NC_000002.12:g.96254117T>G
  • NG_027695.1:g.16897A>C
  • NM_001193304.3:c.410-2A>C
  • NM_001407282.1:c.158-2A>C
  • NM_001407283.1:c.158-2A>C
  • NM_017849.4:c.410-2A>CMANE SELECT
  • LRG_528t1:c.410-2A>C
  • LRG_528:g.16897A>C
  • NC_000002.11:g.96919855T>G
  • NM_017849.3:c.410-2A>C
Nucleotide change:
IVS3AS, A-C, -2
Links:
OMIM: 613403.0001; dbSNP: rs121908826
NCBI 1000 Genomes Browser:
rs121908826
Molecular consequence:
  • NM_001193304.3:c.410-2A>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407282.1:c.158-2A>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001407283.1:c.158-2A>C - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_017849.4:c.410-2A>C - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
Pheochromocytoma, susceptibility to
Identifiers:
MedGen: C3149711

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000020270OMIM
no assertion criteria provided
risk factor
(Mar 1, 2010)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Penetrance and clinical features of pheochromocytoma in a six-generation family carrying a germline TMEM127 mutation.

Toledo SP, Lourenço DM Jr, Sekiya T, Lucon AM, Baena ME, Castro CC, Bortolotto LA, Zerbini MC, Siqueira SA, Toledo RA, Dahia PL.

J Clin Endocrinol Metab. 2015 Feb;100(2):E308-18. doi: 10.1210/jc.2014-2473. Epub 2014 Nov 12.

PubMed [citation]
PMID:
25389632

Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.

Qin Y, Yao L, King EE, Buddavarapu K, Lenci RE, Chocron ES, Lechleiter JD, Sass M, Aronin N, Schiavi F, Boaretto F, Opocher G, Toledo RA, Toledo SP, Stiles C, Aguiar RC, Dahia PL.

Nat Genet. 2010 Mar;42(3):229-33. doi: 10.1038/ng.533. Epub 2010 Feb 14.

PubMed [citation]
PMID:
20154675
PMCID:
PMC2998199
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000020270.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

In 7 members of a family with autosomal dominant inheritance of pheochromocytoma (171300), originally reported by Dahia et al. (2005), Qin et al. (2010) identified a heterozygous germline A-to-C transversion in intron 3 of the TMEM127 gene, resulting in a frameshift and premature termination. Two affected individuals from another unrelated family carried the same mutation, but haplotype analysis excluded a common ancestor. Analysis of all tumor tissues showed loss of heterozygosity at the TMEM127 locus, consistent with a 2-hit model of tumor suppressor inactivation. Age at onset ranged from 34 to 54 years in the first family and from 34 to 42 years in the second family. TMEM127 expression was decreased, consistent with a loss of function.

Toledo et al. (2015) offered genetic counseling, testing, and follow-up to 151 members of the 6-generation family carrying the c.410-2A-C mutation studied by Qin et al. (2010) and Dahia et al. (2005). Forty-seven individuals were found to carry the mutation. Clinical data were available for 34 mutation-positive individuals who were followed for 1 to 20 years (mean 8.7 years). Pheochromocytoma was diagnosed in 11 (32%) at a median age of 43 years. Two patients were asymptomatic, and 9 had symptoms starting on average at age 29 (range 10-55 years). Tumors were multicentric in 5 and bilateral in 5 patients. Over half had at least 1 adrenomedullary nodule less than 10 mm. No paragangliomas, distant metastases, or other manifestations were reported.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024